[Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications].

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gastroentérologie Clinique et Biologique

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17396083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural history and predictors of disease severity in chronic hepatitis C.

  2006cited by this paper
• Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients

  2006cited by this paper
• Diabetes in chronic liver disease: from old concepts to new evidence

  2006cited by this paper
• Endothelial inflammation in insulin resistance.

  2005cited by this paper
• New‐onset diabetes after liver transplantation: From pathogenesis to management

  2005cited by this paper
• Clinical characteristics and outcome of patients with cirrhosis and refractory ascites

  2004cited by this paper
• Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.

  2004cited by this paper
• The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.

  2003cited by this paper
• Novel concepts in insulin regulation of hepatic gluconeogenesis.

  2003cited by this paper
• Tumor necrosis factor–α–induced insulin resistance may mediate the hepatitis C virus–diabetes association

  2003cited by this paper
• Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation.

  2003cited by this paper
• GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis.

  2002cited by this paper
• Ethanol, oxidative stress, and cytokine-induced liver cell injury.

  2002cited by this paper
• Inflammatory status and insulin resistance

  2002cited by this paper
• Risk factors of fibrosis in alcohol‐induced liver disease

  2002cited by this paper
• High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

  2001cited by this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cited by this paper
• Disturbed Synthesis of Insulinlike Growth Factor I and Its Binding Proteins May Influence Renal Function Changes in Liver Cirrhosis

  2001cited by this paper
• Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.

  1999cited by this paper
• Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

  1999cited by this paper
• Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients

  1999cited by this paper
• Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation

  1999cited by this paper
• Insulin signalling: metabolic pathways and mechanisms for specificity.

  1999cited by this paper
• Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: A long‐term prospective study

  1999cited by this paper
• Impaired splanchnic and peripheral glucose uptake in liver cirrhosis.

  1999cited by this paper
• Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

  1999cited by this paper
• Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis.

  1999cited by this paper
• Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.

  1998cited by this paper
• Impaired nonoxidative glucose metabolism in patients with liver cirrhosis: effects of two insulin doses.

  1997cited by this paper
• REVIEW: The controversy over the pathophysiology of ascites formation in cirrhosis

  1997cited by this paper
• Glucose load and renal sodium handling in mild essential hypertension on different sodium intakes.

  1996cited by this paper
• Excess risk of primary liver cancer in patients with diabetes mellitus.

  1996cited by this paper
• Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

  1994cited by this paper
• Prognostic significance of diabetes in patients with cirrhosis

  1994cited by this paper
• Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients.

  1993cited by this paper
• Metabolic handling of orally administered glucose in cirrhosis.

  1993cited by this paper
• Normal splanchnic but impaired peripheral insulin‐stimulated glucose uptake in cirrhosis

  1993cited by this paper
• Mechanism of insulin resistance associated with liver cirrhosis.

  1992cited by this paper
• Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition.

  1992cited by this paper
• Hemodynamic effects of glucagon in portal hypertension

  1990cited by this paper
• Glucose disposal, beta-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment.

  1990cited by this paper
• Glucose and insulin metabolism in cirrhosis.

  1989cited by this paper
• Role of Prostacyclin in the Splanchnic Hyperemia Contributing to Portal Hypertension

  1989cited by this paper
• The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis

  1988cited by this paper
• Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells.

  1988cited by this paper
• Growth Hormone and Carbohydrate Intolerance in Cirrhosis

  1988cited by this paper
• Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance.

  1988cited by this paper
• Insulin sensitivity in the intact organism.

  1987cited by this paper
• Diabetes mellitus and primary hepatocellular carcinoma.

  1986cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Liver perisinusoidal fibrosis in BB rats with or without overt diabetes.

  1985cited by this paper
• Insulin action in cirrhosis

  1985cited by this paper
• Diabetes mellitus in chronic active hepatitis and cirrhosis.

  1984cited by this paper
• C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

  1984cited by this paper
• Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension.

  1984cited by this paper
• Glucose intolerance in liver cirrhosis.

  1982cited by this paper
• Ultrastructural Aspects of the Liver Perisinusoidal Space in Diabetic Patients With and Without Microangiopathy

  1982cited by this paper
• Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy.

  1981cited by this paper
• Mechanism of action of glucagon on hepatocyte phosphofructokinase activity.

  1980cited by this paper
• Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

  1977cited by this paper
• Capillarization of hepatic sinusoids in man.

  1963cited by this paper

• Glucose Metabolism Disorders in Cirrhosis: Frequency and Risk Factors in Tunisian Population. Results of a Cross-Sectional Study

  2014cites this paper
• Perioperative predictors for refractory hyperglycemia during the neohepatic phase of liver transplantation.

  2014cites this paper
• Resistin Hormone A Possible Marker of Insulin resistance in chronic HCV and Type 2 Diabetic patients

  2014cites this paper
• Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study

  2012cites this paper